Results 221 to 230 of about 17,342 (262)
m6A‐Mediated Glycolysis by IL‐37 Drives T Cell Metabolic Reprogramming to Regulate Colitis
This study identifies an IL‐37/SIGIRR‐METTL14 regulatory axis that suppresses global m6A modification in CD4+ T cells. IL‐37 signaling, mediated through SIGIRR, inhibits IRAK4 and JNK phosphorylation, leading to downregulation of the methyltransferase METTL14.
Xiaoyan Wang +26 more
wiley +1 more source
In rheumatoid arthritis, synovial Tregs accumulate but are functionally impaired due to iron overload‐induced ferroptosis. This triggers mitochondrial dysfunction and TXK tyrosine kinase‐mediated signaling, leading to Treg destabilization and inflammation.
Jingrong Chen +19 more
wiley +1 more source
We propose the Full‐Body AI Agent, a multi‐scale collaborative framework with 7 biological‐layer agents. It unifies multi‐omics/clinical data via standardized protocols, enabling phenotype‐guided closed‐loop reasoning, quantitative evaluation, and LLM safeguards, with promising applications in tumor metastasis modeling and precision drug development ...
Aoqi Wang +11 more
wiley +1 more source
T Cell Exhaustion in Cancer Immunotherapy: Heterogeneity, Mechanisms, and Therapeutic Opportunities
T cell exhaustion limits immunotherapy efficacy. This article delineates its progression from stem‐like to terminally exhausted states, governed by persistent antigen, transcription factors, epigenetics, and metabolism. It maps the exhaustion landscape in the TME and proposes integrated reversal strategies, providing a translational roadmap to overcome
Yang Yu +7 more
wiley +1 more source
Network‐based Approaches in Pharmacology [PDF]
AbstractIn drug discovery, network‐based approaches are expected to spotlight our understanding of drug action across multiple layers of information. On one hand, network pharmacology considers the drug response in the context of a cellular or phenotypic network.
Karine Audouze +2 more
exaly +3 more sources
Network pharmacology: curing causal mechanisms instead of treating symptoms [PDF]
Para enfermedades complejas, la mayoría de los medicamentos son altamente ineficaces y la tasa de éxito del descubrimiento de fármacos está en constante declive. Si bien la baja calidad, los problemas de reproducibilidad y la irrelevancia traslacional de la mayoría de las investigaciones básicas y preclínicas han contribuido a esto, la actual ...
Cristian Nogales +2 more
exaly +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Information Loss in Network Pharmacology
Molecular Informatics, 2019AbstractWith the advent of increasing computational power and large‐scale data acquisition, network analysis has become an attractive tool to study the organisation of complex systems and the interrelation of their constituent entities in various scientific domains.
Ingo, Vogt, Jordi, Mestres
openaire +2 more sources
“Network Target” Theory and Network Pharmacology
2021In the biomedical big data and artificial intelligence era, pioneering interdisciplinary information science research, life science, and medicine are represented by a complex biological network which has attracted increasing attention from researchers.
Shao Li, Qingyang Ding, Xin Wang
openaire +1 more source
Network Pharmacology of Glioblastoma
Current Drug Discovery Technologies, 2013With increasing knowledge of cellular networks of gene and molecular interactions, and their alterations in GBM (glioblastoma multiforme), it is now possible to apply methods of Network Pharmacology (NP) to predict candidate drug targets for this malignant brain tumor.
openaire +2 more sources
Drug Repositioning Through Network Pharmacology
Current Topics in Medicinal Chemistry, 2016Low drug productivity has been a significant problem of the pharmaceutical industry for several decades even though numerous novel technologies were introduced during this period. Currently pharmacologic dogma, "single drug, single target, single disease", is at the root of the lack of drug productivity.
Hao, Ye +4 more
openaire +2 more sources

